Opportunities Preloader

Please Wait.....

Report

Ventricular Assist Devices Market Report by Product (Left Ventricular Assist Device (LVAD), Right Ventricular Assist Device (RVAD), Biventricular Assist Device (BiVAD), and Others), Flow Type (Pulsatile Flow, Non-Pulsatile or Continuous Flow), Product Type (Implantable Ventricular Assist Devices, Non-implantable Ventricular Assist Devices), Application (Bridge-to-Transplant (BTT) Therapy, Destination Therapy, Bridge to Recovery and Bridge to Candidacy), End User (Ambulatory Surgery Centers, Hospital, and Others), and Region 2024-2032

Market Report I 2024-04-08 I 135 Pages I IMARC Group

The global ventricular assist devices market size reached US$ 1.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.1 Billion by 2032, exhibiting a growth rate (CAGR) of 8.5% during 2024-2032. The growing prevalence of heart failure, limited availability of donor hearts, supportive regulatory framework and faster approvals, improvements in surgical techniques for VAD implantation, and technological advancements represent some of the key factors propelling the market.

Ventricular assist devices (VADs) are medical devices designed to support the functioning of a weakened or failing heart. They are primarily used as a temporary measure while a patient awaits a heart transplant or as a long-term solution for patients who are not eligible for transplantation. VADs are implanted surgically and help pump blood from the heart's ventricles to the rest of the body. These devices consist of a pump, which is typically placed in the patient's abdomen or chest, and a driveline that connects the pump to an external power source. The pump is responsible for taking over the pumping action of the heart, ensuring that blood is adequately circulated throughout the body. They can help relieve symptoms, including fatigue, shortness of breath, and fluid retention. Moreover, VADs can serve as a bridge to transplantation, keeping patients stable and improving their chances of receiving a donor heart. As a result, VADs have revolutionized the treatment of heart failure, providing patients with improved quality of life, higher energy levels, and increased survival rates.

A rise in the prevalence of cardiovascular diseases (CVDs) represents one of the key factors driving market growth. Besides this, the growing awareness among healthcare professionals and patients about the benefits and availability of VAD therapy is contributing to the market expansion. A surge in efforts to educate healthcare providers, patients, and caregivers about the effectiveness of VADs in managing heart failure has led to increased acceptance and adoption of these devices. In addition, supportive regulatory frameworks and approvals have facilitated the commercialization and adoption of VADs. Regulatory agencies worldwide have been actively involved in streamlining the approval process, ensuring safety, and promoting innovation in VAD technology. Such favorable regulatory environments encourage manufacturers to invest in research and development (R&D) and introduce advanced VADs. Additionally, advancements in surgical techniques for VAD implantation have made the procedure safer and more accessible. The introduction of minimally invasive (MI) surgical approaches, such as thoracotomy or subcostal incisions, has reduced surgical trauma, shortened recovery times, and expanded the eligibility of patients for VAD therapy, which in turn has accelerated the adoption of VADs. Furthermore, the increasing healthcare expenditure, particularly in emerging economies, is contributing to the growth of the VADs market. Other factors, including significant economic growth, improving healthcare infrastructure, favorable government initiatives to enhance healthcare access, and the rising willingness of patients to invest in novel treatment options for heart failure, are also anticipated to stimulate market growth.

Ventricular Assist Devices Market Trends/Drivers:
Increase in the prevalence of heart failure

The growing prevalence of heart failure across the globe is a significant factor driving the market for ventricular assist devices. The rise in heart failure cases can be attributed to the aging population, sedentary lifestyles of individuals, obesity, and an increase in chronic diseases such as diabetes and hypertension. The risk of heart failure rises with age, and older adults are more likely to require mechanical circulatory support. The aging population, especially in developed countries, creates a substantial patient pool for VADs, fueling market growth. As the number of heart failure patients continues to grow, the demand for VADs as a viable treatment option also increases. VADs offer a solution for individuals with advanced heart failure who may not respond adequately to conventional therapies, providing mechanical support and improving their quality of life.

Limited availability of donor hearts

The scarcity of suitable donor hearts for transplantation is another critical factor strengthening the market growth. Heart transplantation remains the gold standard treatment for end-stage heart failure. However, the number of available donor hearts falls significantly short of the demand. Since VADs serve as a bridge to transplantation, keeping patients stable and improving their chances of receiving a donor heart, they are increasingly being used as a long-term solution for patients who are not eligible for transplantation. As a result, the limited availability of suitable heart donors has generated the need for alternatives to heart transplantation, such as VADs, which is further expected to fuel the growth of the market during the forecast period.

Rise in technological advancements

Rapid advancements in VAD technology have significantly contributed to the growth of the market. Continuous research and development (R&D) efforts by key players have led to smaller device sizes, improved durability, enhanced control systems, and better patient outcomes. These technological advancements have expanded the use of VADs to a broader patient population, including those with smaller body sizes or children with heart failure. Moreover, advancements in device design and implantation techniques have reduced the risk of complications, increased device reliability, and improved patient comfort. Such innovations and improvements in VAD technology have led to the development of innovative devices that are more efficient, safer, and appealing to both healthcare professionals and patients, thereby supporting market growth.

Ventricular Assist Devices Industry Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global ventricular assist devices market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on product, flow type, product type, application, and end user.

Breakup by Product:
Left Ventricular Assist Device (LVAD)
Right Ventricular Assist Device (RVAD)
Biventricular Assist Device (BiVAD)
Others

Left ventricular assist device (LVAD) represents the most popular product

The report has provided a detailed breakup and analysis of the market based on the product. This includes left ventricular assist device (LVAD), right ventricular assist device (RVAD), biventricular assist device (BiVAD), and others. According to the report, left ventricular assist device (LVAD) represented the largest segment.

Breakup by Flow Type:

Pulsatile Flow
Non-Pulsatile or Continuous Flow

Non-pulsatile or continuous flow dominates the market

The report has provided a detailed breakup and analysis of the market based on the flow type. This includes pulsatile flow and non-pulsatile or continuous flow. According to the report, non-pulsatile or continuous flow represented the largest segment.

Breakup by Product Type:

Implantable Ventricular Assist Devices
Non-implantable Ventricular Assist Devices

Implantable ventricular assist devices represent the largest product type

The report has provided a detailed breakup and analysis of the market based on the product type. This includes implantable ventricular assist devices and non-implantable ventricular assist devices. According to the report, implantable ventricular assist devices represented the largest segment.

Breakup by Application:

Bridge-to-Transplant (BTT) Therapy
Destination Therapy
Bridge to Recovery and Bridge to Candidacy

Bridge-to-transplant (BTT) therapy accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the application. This includes bridge-to-transplant (BTT) therapy, destination therapy, and bridge to recovery and bridge to candidacy. According to the report, bridge-to-transplant (BTT) therapy represented the largest segment.

Breakup by End User:

Ambulatory Surgery Centers
Hospital
Others

Hospital holds the leading position in the market

The report has provided a detailed breakup and analysis of the market based on the end user. This includes ambulatory surgery centers, hospital, and others. According to the report, hospital represented the largest segment.

Breakup by Region:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

North America exhibits a clear dominance in the market

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for ventricular assist devices.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Abbott Laboratories
Abiomed Inc.
Berlin Heart GmbH (Syscore GmbH)
Bivacor Inc.
Calon Cardio
Cardiacassist Inc. (LivaNova PLC)
CHF Solutions Inc.
Jarvik Heart Inc.
MAQUET GmbH (Getinge)
Medtronic Inc.
Syncardia Systems LLC (Versa Capital Management LLC)
TandemLife (LivaNova PLC)
Terumo Corporation

Key Questions Answered in This Report

1. How big is the global ventricular assist devices market?
2. What is the expected growth rate of the global ventricular assist devices market during 2024-2032?
3. What are the key factors driving the global ventricular assist devices market?
4. What has been the impact of COVID-19 on the global ventricular assist devices market?
5. What is the breakup of the global ventricular assist devices market based on the product?
6. What is the breakup of the global ventricular assist devices market based on the flow type?
7. What is the breakup of the global ventricular assist devices market based on the product type?
8. What is the breakup of the global ventricular assist devices market based on the application?
9. What is the breakup of the global ventricular assist devices market based on the end-user?
10. What are the key regions in the global ventricular assist devices market?
11. Who are the key players/companies in the global ventricular assist devices market?

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Ventricular Assist Device Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Left Ventricular Assist Device (LVAD)
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Right Ventricular Assist Device (RVAD)
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Biventricular Assist Device (BiVAD)
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Others
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by Flow Type
7.1 Pulsatile Flow
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Non-Pulsatile or Continuous Flow
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Product Type
8.1 Implantable Ventricular Assist Devices
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Non-implantable Ventricular Assist Devices
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by Application
9.1 Bridge-to-Transplant (BTT) Therapy
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Destination Therapy
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Bridge to Recovery and Bridge to Candidacy
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by End-User
10.1 Ambulatory Surgery Centers
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Hospitals
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Others
10.3.1 Market Trends
10.3.2 Market Forecast
11 Market Breakup by Region
11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2 Asia Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3 Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast
12 SWOT Analysis
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 Price Indicators
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 Abbott Laboratories
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.1.3 Financials
16.3.1.4 SWOT Analysis
16.3.2 Abiomed Inc.
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.2.3 Financials
16.3.2.4 SWOT Analysis
16.3.3 Berlin Heart GmbH (Syscore GmbH)
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.3.3 Financials
16.3.4 Bivacor Inc.
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.5 Calon Cardio
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.5.3 Financials
16.3.6 Cardiacassist Inc. (LivaNova PLC)
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.7 CHF Solutions Inc.
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.7.3 Financials
16.3.8 Jarvik Heart Inc.
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.9 MAQUET GmbH (Getinge)
16.3.9.1 Company Overview
16.3.9.2 Product Portfolio
16.3.9.3 Financials
16.3.9.4 SWOT Analysis
16.3.10 Medtronic Inc.
16.3.10.1 Company Overview
16.3.10.2 Product Portfolio
16.3.11 Syncardia Systems LLC (Versa Capital Management LLC)
16.3.11.1 Company Overview
16.3.11.2 Product Portfolio
16.3.11.3 SWOT Analysis
16.3.12 TandemLife (LivaNova Plc)
16.3.12.1 Company Overview
16.3.12.2 Product Portfolio
16.3.13 Terumo Corporation
16.3.13.1 Company Overview
16.3.13.2 Product Portfolio
16.3.13.3 Financials
16.3.13.4 SWOT Analysis

Figure 1: Global: Ventricular Assist Device Market: Major Drivers and Challenges
Figure 2: Global: Ventricular Assist Device Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Ventricular Assist Device Market: Breakup by Product (in %), 2023
Figure 4: Global: Ventricular Assist Device Market: Breakup by Flow Type (in %), 2023
Figure 5: Global: Ventricular Assist Device Market: Breakup by Product Type (in %), 2023
Figure 6: Global: Ventricular Assist Device Market: Breakup by Application (in %), 2023
Figure 7: Global: Ventricular Assist Device Market: Breakup by End-User (in %), 2023
Figure 8: Global: Ventricular Assist Device Market: Breakup by Region (in %), 2023
Figure 9: Global: Ventricular Assist Device Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 10: Global: Ventricular Assist Device (Left Ventricular Assist Device) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Ventricular Assist Device (Left Ventricular Assist Device) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Ventricular Assist Device (Right Ventricular Assist Device) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Ventricular Assist Device (Right Ventricular Assist Device) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Ventricular Assist Device (Biventricular Assist Device) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Ventricular Assist Device (Biventricular Assist Device) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Ventricular Assist Device (Other Products) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Ventricular Assist Device (Other Products) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Ventricular Assist Device (Pulsatile Flow) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Ventricular Assist Device (Pulsatile Flow) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Ventricular Assist Device (Non-Pulsatile or Continuous Flow) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Ventricular Assist Device (Non-Pulsatile or Continuous Flow) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Ventricular Assist Device (Implantable Ventricular Assist Devices) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Ventricular Assist Device (Implantable Ventricular Assist Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Ventricular Assist Device (Non-implantable Ventricular Assist Devices) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Ventricular Assist Device (Non-implantable Ventricular Assist Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Global: Ventricular Assist Device (Bridge-to-Transplant Therapy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: Ventricular Assist Device (Bridge-to-Transplant Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Global: Ventricular Assist Device (Destination Therapy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Global: Ventricular Assist Device (Destination Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Global: Ventricular Assist Device (Bridge to Recovery and Bridge to Candidacy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Global: Ventricular Assist Device (Bridge to Recovery and Bridge to Candidacy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: Global: Ventricular Assist Device (Ambulatory Surgery Centers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: Global: Ventricular Assist Device (Ambulatory Surgery Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: Global: Ventricular Assist Device (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: Global: Ventricular Assist Device (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: Global: Ventricular Assist Device (Other End-Users) Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: Global: Ventricular Assist Device (Other End-Users) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: North America: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: North America: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: United States: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: United States: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: Canada: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: Canada: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: Asia Pacific: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: Asia Pacific: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: China: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: China: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: Japan: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: Japan: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: India: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: India: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: South Korea: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: South Korea: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: Australia: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: Australia: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Indonesia: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Indonesia: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: Others: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: Others: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Europe: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Europe: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Germany: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Germany: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: France: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: France: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: United Kingdom: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: United Kingdom: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Italy: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Italy: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Spain: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Spain: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Russia: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Russia: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: Others: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
Figure 75: Others: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 76: Latin America: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
Figure 77: Latin America: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 78: Brazil: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
Figure 79: Brazil: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 80: Mexico: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
Figure 81: Mexico: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 82: Others: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
Figure 83: Others: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 84: Middle East and Africa: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
Figure 85: Middle East and Africa: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 86: Global: Ventricular Assist Device Industry: SWOT Analysis
Figure 87: Global: Ventricular Assist Device Industry: Value Chain Analysis
Figure 88: Global: Ventricular Assist Device Industry: Porters Five Forces Analysis

Table 1: Global: Ventricular Assist Device Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Ventricular Assist Device Market Forecast: Breakup by Product (in Million US$), 2024-2032
Table 3: Global: Ventricular Assist Device Market Forecast: Breakup by Flow Type (in Million US$), 2024-2032
Table 4: Global: Ventricular Assist Device Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
Table 5: Global: Ventricular Assist Device Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 6: Global: Ventricular Assist Device Market Forecast: Breakup by End-User (in Million US$), 2024-2032
Table 7: Global: Ventricular Assist Device Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 8: Global: Ventricular Assist Device Market Structure
Table 9: Global: Ventricular Assist Device Market: Key Players

  • Not Sure / Need Reassuring
    • Confirm Content
      • Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:

        Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.

        Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.

        Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.

    • Sample Pages
      • With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.

        It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.

        To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Check for Alternatives
      • Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.

        To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.

  • Prices / Formats / Delivery
    • Prices
      • All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.

        Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Discounts
      • As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.

        Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.

        To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Available Currencies
      • Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.

        Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.

        To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.

    • Licenses
      • License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Global Site License
      • The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.

        It is important to note that this may exclude Parent Companies or Subsidiaries.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Formats
      • The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.

        If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.

    • Delivery
      • Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.

        Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.

        If a delay in delivery is expected you will be informed about it immediately.

    • Shipping Charges
      • As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.

        If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.

  • Ordering
    • By Credit Card
      • We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.

        Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.

        For more information on PayU please visit: https://www.payu.pl/en/about-us

    • By Money Transfer
      • If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.

        With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.

  • Security
    • Website security
      • We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.

        Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.

    • Credit Card Security
      • We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.

        PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.

PLEASE SELECT LICENSE
  • $3899.00
  • $4899.00
  • $5899.00
  • ADD TO BASKET
  • BUY NOW